Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xi Shi

Showing results (331-340 of 344) with videos related to

Pageof 35
Sort By:
Nature|February 5, 2025
H-bonded organic frameworks as ultrasound-programmable delivery platformWenliang Wang, Yanshu Shi, Wenrui Chai, et al.
Journal of Medicinal Chemistry|June 11, 2015
Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain InhibitorWylie S Palmer, Guillaume Poncet-Montange, Gang Liu, et al.
Signal Transduction and Targeted Therapy|June 10, 2022
LDL receptor-related protein 1 (LRP1), a novel target for opening the blood-labyrinth barrier (BLB)Xi Shi, Zihao Wang, Wei Ren, et al.
Epigenetics & Chromatin|September 24, 2015
Development of novel cellular histone-binding and chromatin-displacement assays for bromodomain drug discoveryYanai Zhan, Maria Kost-Alimova, Xi Shi, et al.
Cancer Research|July 4, 2015
The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor StudiesBhavatarini Vangamudi, Thomas A Paul, Parantu K Shah, et al.
Nature Communications|September 24, 2017
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCsYongli Shan, Zechuan Liang, Qi Xing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2015
Hypoxia-Activated Prodrug TH-302 Targets Hypoxic Bone Marrow Niches in Preclinical Leukemia ModelsJuliana Benito, Marc S Ramirez, Niki Zacharias Millward, et al.
The Lancet. Oncology|January 9, 2025
Claudin 18.2-targeting antibody-drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trialDan-Yun Ruan, Fu-Rong Liu, Xiao-Li Wei, et al.
Cancer Cell|November 14, 2006
Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemiaMarina Konopleva, Rooha Contractor, Twee Tsao, et al.
Nature|February 3, 2022
Autism genes converge on asynchronous development of shared neuron classesBruna Paulsen, Silvia Velasco, Amanda J Kedaigle, et al.
Pageof 35

Showing results (331-340 of 344) with videos related to

Sort By:
Pageof 35
Nature|February 5, 2025
H-bonded organic frameworks as ultrasound-programmable delivery platformWenliang Wang, Yanshu Shi, Wenrui Chai, et al.
Journal of Medicinal Chemistry|June 11, 2015
Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain InhibitorWylie S Palmer, Guillaume Poncet-Montange, Gang Liu, et al.
Signal Transduction and Targeted Therapy|June 10, 2022
LDL receptor-related protein 1 (LRP1), a novel target for opening the blood-labyrinth barrier (BLB)Xi Shi, Zihao Wang, Wei Ren, et al.
Epigenetics & Chromatin|September 24, 2015
Development of novel cellular histone-binding and chromatin-displacement assays for bromodomain drug discoveryYanai Zhan, Maria Kost-Alimova, Xi Shi, et al.
Cancer Research|July 4, 2015
The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor StudiesBhavatarini Vangamudi, Thomas A Paul, Parantu K Shah, et al.
Nature Communications|September 24, 2017
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCsYongli Shan, Zechuan Liang, Qi Xing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2015
Hypoxia-Activated Prodrug TH-302 Targets Hypoxic Bone Marrow Niches in Preclinical Leukemia ModelsJuliana Benito, Marc S Ramirez, Niki Zacharias Millward, et al.
The Lancet. Oncology|January 9, 2025
Claudin 18.2-targeting antibody-drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trialDan-Yun Ruan, Fu-Rong Liu, Xiao-Li Wei, et al.
Cancer Cell|November 14, 2006
Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemiaMarina Konopleva, Rooha Contractor, Twee Tsao, et al.
Nature|February 3, 2022
Autism genes converge on asynchronous development of shared neuron classesBruna Paulsen, Silvia Velasco, Amanda J Kedaigle, et al.
Pageof 35